Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis

World Journal of Urology

Volumn 33, Issue 7, 2015, Pages 1023-1030

  Junker, Daniel ^a   Quentin, Michael ^b   Nagele, Udo ^c   Edlinger, Michael ^a   Richenberg, Jonathan ^d   Schaefer, Georg ^a,e   Ladurner, Michael ^a   Jaschke, Werner ^a   Horninger, Wolfgang ^a   Aigner, Friedrich ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Abteilung für Urologie und Andrologie   (Austria)

^d ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^e MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

ESUR guidelines; mpMRI of the prostate; PI RADS; Prostate cancer detection

Indexed keywords

AGED; CANCER GRADING; CANCER STAGING; CARCINOMA; COMPUTER ASSISTED DIAGNOSIS; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEIVER OPERATING CHARACTERISTIC;

AGED; CARCINOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 84933179825     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-014-1370-x     Document Type: Article

References (22)

1. De Rooij M, Hamoen EH, Fütterer JJ, Barentsz JO, Rovers MM (2014) Accuracy of Multiparametric MRI for prostate cancer detection: a meta-AnalysisMaarten. AJR Am J Roentgenol 202(2):343–351. doi:10.2214/AJR.13.11046
2. Murphy G, Haider M, Ghai S, Sreeharsha B (2013) The expanding role of MRI in prostate cancer. AJR Am J Roentgenol 201(6):1229–1238. doi:10.2214/AJR.12.10178
3. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin P, Kirkham AP, Padhani AR, Persad R, Puech P, Punwani S, Sohaib A, Tombal B, Villers A, Emberton M (2012) Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging 37(1):48–58. doi:10.1002/jmri.23689
4. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ (2012) ESUR prostate MR guidelines. Eur Radiol 22(4):746–757. doi:10.1007/s00330-011-2377-y
5. Schimmöller L, Quentin M, Arsov C, Lanzman RS, Hiester A, Rabenalt R, Antoch G, Albers P, Blondin D (2013) Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol 23(11):3185–3190. doi:10.1007/s00330-013-2922-y
6. Rosenkrantz AB, Lim RP, Haghighi M, Somberg MB, Babb JS, Taneja SS (2013) Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. AJR Am J Roentgenol 201(4):W612–W618. doi:10.2214/AJR.12.10173
7. Kuru TH, Roethke MC, Rieker P, Roth W, Fenchel M, Hohenfellner M, Schlemmer HP, Hadaschik BA (2013) Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate. BJU Int 112(8):1054–1055. doi:10.1111/bju.12307
8. Portalez D, Mozer P, Cornud F, Renard-Penna R, Misrai V, Thoulouzan M, Malavaud B (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62(6):986–996. doi:10.1016/j.eururo.2012.06.044
9. Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, Schlemmer HP, Hadaschik BA (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24(2):344–352. doi:10.1007/s00330-013-3017-5
10. Junker D, Schäfer G, Edlinger M, Kremser C, Bektic J, Horninger W, Jaschke W, Aigner F (2013) Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer. Biomed Res Int 2013:252939. doi:10.1155/2013/252939
11. Roethke M, Blondin D, Schlemmer HP, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 185(3):253–261. doi:10.1055/s-0032-1330270
12. Hoeks CM, Somford DM, van Oort IM, Vergunst H, Oddens JR, Smits GA, Roobol MJ, Bul M, Hambrock T, Witjes JA, Fütterer JJ, Hulsbergen-van de Kaa CA, Barentsz JO (2014) Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study. Invest Radiol 49(3):165–172. doi:10.1097/RLI.0000000000000008
13. D’Orsi CJ, Newell MS (2007) BI-RADS decoded: detailed guidance on potentially confusing issues. Radiol Clin North Am 45:751–763
14. Moore CM, Robertson NL, Arsanious N, Middleton T, Villers A, Klotz L, Taneja SS, Emberton M (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140. doi:10.1016/j.eururo.2012.06.004
15. Haffner J, Lemaitre L, Puech P, Haber GP, Leroy X, Jones JS, Villers A (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection. BJU Int 108(8 Pt 2):E171–E178. doi:10.1111/j.1464-410X.2011.10112.x
16. Parker C, Muston D, Melia J, Moss S, Dearnaley D (2006) A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer 94(10):1361–1368
17. Wolters T, Roobol MJ, Leeuwen PJV, van den Bergh RC, Hoedemaeker RF, van Leenders GJ, Schröder FH, van der Kwast TH (2011) A Critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185(1):121–125. doi:10.1016/j.juro.2010.08.082
18. Kirkham AP, Haslam P, Keanie JY, McCafferty I, Padhani AR, Punwani S, Richenberg J, Rottenberg G, Sohaib A, Thompson P, Turnbull LW, Kurban L, Sahdev A, Clements R, Carey BM, Allen C (2013) Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol 68(10):1016–1023. doi:10.1016/j.crad.2013.03.030
19. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30(2):327–334. doi:10.1002/jmri.21824
20. Oto A, Kayhan A, Jiang Y, Tretiakova M, Yang C, Antic T, Dahi F, Shalhav AL, Karczmar G, Stadler WM (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723. doi:10.1148/radiol.10100021
21. Rosenkrantz AB, Kim S, Lim RP, Hindman N, Deng FM, Babb JS, Taneja SS (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269(2):482–492. doi:10.1148/radiol.13122233
22. Westphalen AC, Rosenkrantz AB (2014) Prostate imaging reporting and data system (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. AJR Am J Roentgenol 202(1):121–123. doi:10.2214/AJR.13.10889